263 related articles for article (PubMed ID: 29023425)
1. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
3. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
4. New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
Peña I; Pilar Manzano M; Cantizani J; Kessler A; Alonso-Padilla J; Bardera AI; Alvarez E; Colmenarejo G; Cotillo I; Roquero I; de Dios-Anton F; Barroso V; Rodriguez A; Gray DW; Navarro M; Kumar V; Sherstnev A; Drewry DH; Brown JR; Fiandor JM; Julio Martin J
Sci Rep; 2015 Mar; 5():8771. PubMed ID: 25740547
[TBL] [Abstract][Full Text] [Related]
5. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
Don R; Ioset JR
Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
7. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
Roquero I; Cantizani J; Cotillo I; Manzano MP; Kessler A; Martín JJ; McNamara CW
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():58-68. PubMed ID: 31158574
[TBL] [Abstract][Full Text] [Related]
8. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.
Porta EOJ; Ballari MS; Carlucci R; Wilkinson S; Ma G; Tekwani BL; Labadie GR
Eur J Med Chem; 2023 Jun; 254():115378. PubMed ID: 37084599
[TBL] [Abstract][Full Text] [Related]
9. Trypanocidal activity of marine natural products.
Jones AJ; Grkovic T; Sykes ML; Avery VM
Mar Drugs; 2013 Oct; 11(10):4058-82. PubMed ID: 24152565
[TBL] [Abstract][Full Text] [Related]
10. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
12. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Di Pietro O; Vicente-García E; Taylor MC; Berenguer D; Viayna E; Lanzoni A; Sola I; Sayago H; Riera C; Fisa R; Clos MV; Pérez B; Kelly JM; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2015 Nov; 105():120-37. PubMed ID: 26479031
[TBL] [Abstract][Full Text] [Related]
13. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors.
Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G
Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765
[TBL] [Abstract][Full Text] [Related]
14. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antikinetoplastid activity of a series of N,N'-substituted diamines.
Caminos AP; Panozzo-Zenere EA; Wilkinson SR; Tekwani BL; Labadie GR
Bioorg Med Chem Lett; 2012 Feb; 22(4):1712-5. PubMed ID: 22248858
[TBL] [Abstract][Full Text] [Related]
16. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids.
Kaiser M; Maes L; Tadoori LP; Spangenberg T; Ioset JR
J Biomol Screen; 2015 Jun; 20(5):634-45. PubMed ID: 25690568
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
[TBL] [Abstract][Full Text] [Related]
19. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
[TBL] [Abstract][Full Text] [Related]
20. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]